Xènia Ferrer-Cortès

Xènia Ferrer-Cortès

Auto-generated profile, based on publicly available information

Xènia Ferrer-Cortès

Iron Metabolism: Regulation and Diseases, Department of Basic Sciences, Universitat Internacional de Catalunya (UIC), 08195 Sant Cugat del Vallès, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
FTFrederic Tort
Frederic Tort
XFXènia Ferrer-Cortès
Xènia Ferrer-Cortès
MTMarta Thió
Marta Thió
ANAleix Navarro-Sastre
Aleix Navarro-Sastre
LMLeslie Matalonga
Leslie Matalonga
ARAntonia Ribes
Antonia Ribes
Cofactor disorders of mitochondrial energy metabolism are a heterogeneous group of diseases with a wide variety of clinical symptoms, particular metabolic profiles and variable enzymatic defects. Mutations in NFU1, BOLA3, LIAS and IBA57 have been identified in patients with deficient lipoic acid-dependent enzymatic activities and defects in the assembly and activity of the mitochondrial respiratory chain complexes. Here, we report a patient with an early onset fatal lactic acidosis presenting a biochemical phenotype compatible with a combined defect of pyruvate dehydrogenase (PDHC) and 2-ketoglutarate dehydrogenase (2-KGDH) activities, which suggested a deficiency in lipoic acid metabolism. Immunostaining analysis showed that lipoylated E2-PDH and E2-KGDH were extremely reduced in this patient. However, the absence of glycine elevation, the normal activity of the glycine cleavage system and the normal lipoylation of the H protein suggested a defect of lipoic acid transfer to particular proteins rather than a general impairment of lipoic acid biosynthesis as the potential cause of the disease. By analogy with yeast metabolism, we postulated LIPT1 as the altered candidate gene causing the disease. Sequence analysis of the human LIPT1 identified two heterozygous missense mutations (c.212C>T and c.292C>G), segregating in different alleles. Functional complementation experiments in patient's fibroblasts demonstrated that these mutations are disease-causing and that LIPT1 protein is required for lipoylation and activation of 2-ketoacid dehydrogenases in humans. These findings expand the spectrum of genetic defects associated with lipoic acid metabolism and provide the first evidence of a lipoic acid transfer defect in humans.

1 September 2016 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
FTFrederic Tort
Frederic Tort
XFXènia Ferrer‐Cortes
Xènia Ferrer‐Cortes
ARAntonia Ribes
Antonia Ribes

3 May 2013 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
FTFrederic Tort
Frederic Tort
MGMaría Teresa García-Silva
María Teresa García-Silva
XFXènia Ferrer-Cortès
Xènia Ferrer-Cortès
ANAleix Navarro-Sastre
Aleix Navarro-Sastre
JGJudith Garcia-Villoria
Judith Garcia-Villoria
ARAntonia Ribes
Antonia Ribes

22 November 2012 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
XFXènia Ferrer‐Cortès
Xènia Ferrer‐Cortès
AFAida Font
Aida Font
NBNúria Bujan
Núria Bujan
ANAleix Navarro‐Sastre
Aleix Navarro‐Sastre
LMLeslie Matalonga
Leslie Matalonga
FTFrederic Tort
Frederic Tort

1 October 2015 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
LMLeslie Matalonga
Leslie Matalonga
ÁAÁngela Arias
Ángela Arias
FTFrederic Tort
Frederic Tort
XFXènia Ferrer-Cortés
Xènia Ferrer-Cortés
JGJudit Garcia-Villoria
Judit Garcia-Villoria
ARAntonia Ribes
Antonia Ribes

1 January 2016 in Mitochondrion
Verified
Journal Article
Closed access
XFXènia Ferrer-Cortès
Xènia Ferrer-Cortès
JNJuan Narbona
Juan Narbona
NBNúria Bujan
Núria Bujan
LMLeslie Matalonga
Leslie Matalonga
MTMireia Del Toro
Mireia Del Toro
FTFrederic Tort
Frederic Tort